| 1. | | Recruiting | Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease |
| 2. | | Recruiting | Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Conditions: Graft vs Host Disease; Healthy; Lymphopenia |
| 3. | | Recruiting | Fludarabine, Low-Dose Total-Body Irradiation, Donor Stem Cell Transplantation, and Immunosuppression Therapy in Treating Patients Who Have Fanconi’s Anemia
Conditions: Fanconi's Anemia; adult acute myeloid leukemia; childhood acute myeloid leukemia; Graft Versus Host Disease; Myelodysplastic Syndromes |
| 4. | | Recruiting | Anti-Thymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia |
| 5. | | Recruiting | Prednisone and Either Cyclosporine of Tacrolimus With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Conditions: Cancer; Graft Versus Host Disease |
| 6. | | Recruiting | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
| 7. | | Recruiting | Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplantation for Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
| 8. | | Recruiting | OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 9. | | Recruiting | Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer; ... |
| 10. | | Recruiting | Sirolimus in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: chronic myeloproliferative disorders; Graft Versus Host Disease; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 11. | | Recruiting | Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; Graft Versus Host Disease; hematopoietic and lymphoid cancer; Neuroblastoma |
| 12. | | Recruiting | Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation
Conditions: Cancer; Graft Versus Host Disease |
| 13. | | Recruiting | Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants
Condition: Graft Versus Host Disease |
| 14. | | Recruiting | Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
Condition: Graft-Versus-Host Disease |
| 15. | | Recruiting | Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Conditions: acute leukemia; chronic myeloproliferative disorders; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease |
| 16. | | Recruiting | Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
| 17. | | Recruiting | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease |
| 18. | | Recruiting | Radiolabeled Monoclonal Antibody Therapy Combined With Total-body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; Graft Versus Host Disease; ... |
| 19. | | Recruiting | Phase I/II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation in Patients With High Risk Hemoglobinopathy
Conditions: Graft Versus Host Disease; Sickle Cell Anemia; Thalassemia |
| 20. | | Recruiting | Study of Unrelated Allogeneic Bone Marrow Transplantation in Patients With Benign Congenital Bone Marrow Failure Disorders
Conditions: Graft Versus Host Disease; Neutropenia; Shwachman syndrome; Red-Cell Aplasia, Pure; Osteopetrosis |
| 21. | | Recruiting | Phase II Study of Allogeneic Bone Marrow or Umbilical Cord Blood Transplantation in Patients With Lysosomal or Peroxisomal Inborn Errors of Metabolism
Conditions: Graft Versus Host Disease; Lysosomal Storage Diseases; Peroxisomal Disorders |
| 22. | | Recruiting | Peripheral Stem Transplantation in Treating Patients With Refractory or Relapsed Lymphoma
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; Lymphoma |
| 23. | | Recruiting | Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Conditions: childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases |
| 24. | | Recruiting | Thymoglobulin to Prevent Acute Graft vs. Host (GvHD) in Patients with Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant
Conditions: Acute myelogenous leukemia (AML); Acute lymphocytic leukemia (ALL); Graft vs. Host Disease (GvHD) |
| 25. | | Recruiting | Blood and Marrow Transplant Clinical Research Network
Conditions: Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; ... |
| 26. | | Recruiting | Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
Conditions: Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ... |
| 27. | | Recruiting | Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
Conditions: Graft vs Host Disease; Hematologic Neoplasm |
| 28. | | Recruiting | Keratinocyte Growth Factor to Prevent Acute GVHD
Condition: Graft-vs-Host Disease |
| 29. | | Recruiting | Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond to Previous Systemic Treatment
Condition: Graft Versus Host Disease |
| 30. | | Recruiting | Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract
Condition: Graft Versus Host Disease |
| 31. | | Recruiting | Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
Condition: Graft Versus Host Disease |
| 32. | | Recruiting | Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Condition: Graft Versus Host Disease |
| 33. | | Recruiting | Dose-finding study using pentostatin for injection in the treatment of steroid-refractory aGvHD
Condition: Acute Graft Versus Host Disease |
| 34. | | Recruiting | Combined Bone Marrow and Kidney Transplant for Multiple Myeloma with Kidney Failure
Conditions: Kidney Failure, Chronic; Multiple Myeloma |
| 35. | | Recruiting | Stem Cell Transplant with Th2/Tc2 Cells to Treat Advanced Breast Cancer
Condition: Breast Neoplasms |
| 36. | | Recruiting | Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances
Conditions: Leukemia; Bone Marrow Transplantation |
| 37. | | Recruiting | Evaluating a New Transplant Regimen for High-Risk Leukemia Patients with Partially Matched Related Donors
Condition: Leukemia |
| 38. | | Recruiting | Improving the Results of Bone Marrow Transplantation for Patients with Severe Congenital Anemias
Conditions: Congenital Hemolytic Anemia; Diamond-Blackfan Anemia |
| 39. | | Recruiting | Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease
Condition: Chronic Granulomatous Disease |
| 40. | | Recruiting | Stem Cell Transplantation to Treat Systemic Mastocytosis
Condition: Mastocytosis |
| 41. | | Recruiting | Stem Cell Transplantation for Metastatic Solid Tumors
Conditions: Cholangiocarcinoma; Colon/Rectal Ca; Bladder Ca; Breast Ca; Basal Cell Ca; Adrenal Ca; Esophageal/Gastric Ca; Hepatocellular Ca; Ovarian Ca; ... |
| 42. | | Recruiting | Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
Conditions: Hematologic Disease; Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome; Myeloproliferative Disorder |
